Counselors in Attalla, AL Accepting Medicare
12 Counselors found. Showing 1 - 12
 Robert Michael Campbell, M.S. Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 425 5th Ave Nw, Attalla, AL 35954 Phone: 256-492-7800 Fax: 256-494-5536 |
 Mrs. Renee Michelle Bellew, LICSW PIP Counselor - Mental Health Medicare: Accepting Medicare Assignments Practice Location: 306 7th Ave Nw, Attalla, AL 35954 Phone: 256-344-5155 Fax: 256-344-5155 |
Molly Beth Dawson, MA Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 425 5th Ave Nw, Attalla, AL 35954 Phone: 256-492-7800 Fax: 256-494-5536 |
Nicole Dumas, MSW Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 425 5th Ave Nw, Attalla, AL 35954 Phone: 256-492-7800 Fax: 256-494-5536 |
Ashley Bradford, MS Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 425 5th Ave Nw, Attalla, AL 35954 Phone: 256-492-7800 |
Stephanie Sherman, MSW Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 425 5th Ave Nw, Attalla, AL 35954 Phone: 256-492-7800 Fax: 256-494-5536 |
Molly Thompson, MSW Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 425 5th Ave Nw, Attalla, AL 35954 Phone: 256-492-7800 Fax: 256-494-5536 |
Mary Teresa Dawson, LCSW Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 425 5th Ave Nw, Attalla, AL 35954 Phone: 256-492-7800 |
Mr. Bryan C Beeman, M.S. Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 425 5th Ave Nw, Attalla, AL 35954 Phone: 256-492-7800 Fax: 256-494-5536 |
Haley Elizabeth Roberts, LICSW Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 309 Case Ave Se, Attalla, AL 35954 Phone: 256-344-3116 |
Megan M Reichert, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 425 5th Ave Nw, Attalla, AL 35954 Phone: 256-492-7800 Fax: 256-494-5536 |
Andrea Parris Bennett, LPC, AADC, NCC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 317 5th Ave Nw, Attalla, AL 35954 Phone: 256-279-7755 Fax: 256-646-2233 |
News Archive
SynCon DNA vaccine shows advantages in magnitude and breadth of immune responses in non-human primates
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that the peer-reviewed journal Molecular Therapy has published a paper entitled "Comparative Analysis of Immune Responses Induced by Vaccination With SIV Antigens by Recombinant Ad5 Vector or Plasmid DNA in Rhesus Macaques." The paper, co-authored by researchers from Merck, University of Pennsylvania School of Medicine, and Inovio Pharmaceuticals, notes that significant advances in the design, formulation, and delivery of DNA plasmid-based vaccines have dramatically increased their ability to induce antigen-specific immune responses.
Keystone molecules in chemical communication, defense have dominant consequences in nature
Naturally occurring "keystone" molecules that have powerful behavioral effects on diverse organisms often play large but unrecognized roles in structuring ecosystems, according to a theory proposed in the June issue of BioScience.
Researchers uncover three-dimensional structure of tetanus toxin protein
"Our discovery could be used to design new medicines", says Pål Stenmark, Associate Professor at the Department of Biochemistry and Biophysics, Stockholm University.
Helicos Biosciences to raise $10 million through private placement
Helicos BioSciences Corporation (NASDAQ: HLCS), a life science company focused on innovative genetic analysis technologies for the research, drug discovery, and diagnostic markets, today announced that it has entered into a definitive agreement with certain new and existing investors, including Atlas Ventures, Flagship Ventures, Highland Capital Partners, Versant Ventures (the "Existing Investors") and Ron Lowy, the Company's chief executive officer, to raise approximately $10 million in gross proceeds in a private placement through the sale of shares of its common stock and warrants.
› Verified 6 days ago